Investigating the impact of empagliflozin on the retina of diabetic mice
CONCLUSION: EMPA mitigates inflammation and preserves BRB structure and function, suggesting that it may prevent DR or serve as an effective early treatment for DR.PMID:38653578 | DOI:10.1177/11206721241247585
Source: European Journal of Ophthalmology - Category: Opthalmology Authors: Juan Chen Shenghui Zhang Yao You Siqi Hu Jiake Tang Chen Chen Wen Wen Ting Tang Qingwen Yu Xuhan Tong Chunyi Wang Wenbin Zhao Xinyan Fu Xingwei Zhang Mingwei Wang Wenyan Gong Source Type: research
More News: Diabetes | Empagliflozin | Endocrinology | Jardiance | Opthalmology | SGLT2 Inhibitors | Sodium | Study | Vitamin A